On June 3, the FDA approved a new indication for Zerbaxa (ceftolozane and tazobactam) for the treatment of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia (HABP/VABP) in patients…
Reader Survey
Please share your feedback! We’re interested to learn more about your experience with American Nurse Journal.